Defective Lung Macrophage Function in Lung Cancer±Chronic Obstructive Pulmonary Disease (COPD/Emphysema)-Mediated by Cancer Cell Production of PGE2?

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Dehle, Francis C ^a,b   Mukaro, Violet R ^a,b   Jurisevic, Craig ^b   Moffat, David ^c   Ahern, Jessica ^a,b   Hodge, Greg ^a,b,d   Jersmann, Hubertus ^a,b,d   Reynolds, Paul N ^a,b,d   Hodge, Sandra ^a,b,d  

^a HANSON INSTITUTE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c Department of Surgical Pathology SA Pathology ^*  (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THIOREDOXIN 2;

ADULT; AGED; ARTICLE; CELL STRAIN U937; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFEROCYTOSIS; ELECTROSPRAY MASS SPECTROMETRY; EMPHYSEMA; ENDOCYTOSIS; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; QUALITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DEMOGRAPHY; DINOPROSTONE; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PHAGOCYTOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SUBCELLULAR FRACTIONS;

EID: 84876845074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061573     Document Type: Article

References (24)

1. Access Economics Report for the Australian Lung Foundation (2008) Economic Impact of COPD and cost effective solutions. Available: http://www.lungfoundation.com.au/lung-information/publications/economic-impact-of-copd-2008. Accessed 2012 Jan 28.
2. Skillrud DM, (1986) COPD: causes, treatment, and risk for lung cancer. Compr Ther 12(11): 13-16.
3. Fong KM, Sekido Y, Gazdar AF, Minna JD, (2003) Lung cancer. 9: Molecular biology of lung cancer: clinical implications. Thorax 58(10): 892-900.
4. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M, (2003) Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 81(4): 289-296.
5. Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M, et al. (2006) Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J 28(3): 486-495.
6. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, et al. (2007) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37(6): 748-755.
7. Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, et al. (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178(2): 139-148.
8. Hodge S, Hodge G, Holmes M, Reynolds PN, (2005) Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 25(3): 447-454.
9. Hodge S, Matthews G, Dean MM, Ahern J, Djukic M, et al. (2009) Therapeutic Role for Mannose Binding Lectin in Cigarette Smoke-induced Lung Inflammation? Evidence from a Murine Model. Am J Respir Cell Mol Biol 42(2): 235-42.
10. Hodge S, Matthews G, Mukaro V, Ahern J, Shivam A, et al. (2011) Cigarette Smoke-induced Changes to Alveolar Macrophage Phenotype and Function is Improved by Treatment with Procysteine. Am J Respir Cell Mol Biol (445) (): 673-81.
11. Tuve S, Chen BM, Liu Y, Cheng TL, Toure P, et al. (2007) Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses. Cancer Res 67(12): 5929-5939.
12. Kim R, Emi M, Tanabe K, (2006) Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 119(2): 254-264.
13. Aronoff DM, Canetti C, Peters-Golden M, (2004) Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 173(1): 559-565.
14. Hodge SJ, Hodge GL, Holmes M, Reynolds PN, (2004) Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease. Cytometry B Clin Cytom 61(1): 27-34.
15. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (2011) Available: www.goldcopd.org/. Accessed 2012 Jan 28.
16. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press.
17. Soriano C, Mukaro V, Hodge G, Ahern J, Holmes M, et al. (2012) Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion? Lung Cancer 77(1): 38-45.
18. Cordts F, Pitson S, Tabeling C, Gibbins I, Moffat DF, et al. (2011) Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease. Life Sciences 89(21-22): 806-811.
19. Vandivier RW, Henson PM, Douglas IS (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129(6): 1673-82. Review.
20. Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, et al. (2009) M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol 182(7): 4415-4422.
21. Taskinen M, Karjalainen-Lindsberg ML, Nyman H, Eerola LM, Leppa S, (2007) A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone. Clin Cancer Res 13(19): 5784-5789.
22. Izzi V, Chiurchiu V, D'Aquilio F, Palumbo C, Tresoldi I, et al. (2009) Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages. Int J Oncol 34(2): 543-550.
23. Kempen EC, Yang P, Felix E, Madden T, Newman RA, (2001) Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem 297(2): 183-190.
24. Watkins DN, Peroni DJ, Lenzo JC, Knight DA, Garlepp MJ, et al. (1999) Expression and localization of COX-2 in human airways and cultured airway epithelial cells. Eur Respir J 13(5): 999-1007.